DSP
Desmoplakin
Also known as: DESP_HUMAN, DPI, DPII, KPPS2, PPKS2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15924
- Gene
- DSP
- Ensembl
- ENSG00000096696
- Chromosome
- 6
- Canonical length
- 2871 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Cell Junctions
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that anchors intermediate filaments to desmosomal plaques and forms an obligate component of functional desmosomes. Mutations in this gene are the cause of several cardiomyopathies and keratodermas, including skin fragility-woolly hair syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
2871 residues, UniProt reviewed canonical sequence.
>P15924|DSP
1 MSCNGGSHPR INTLGRMIRA ESGPDLRYEV TSGGGGTSRM YYSRRGVITD QNSDGYCQTG
61 TMSRHQNQNT IQELLQNCSD CLMRAELIVQ PELKYGDGIQ LTRSRELDEC FAQANDQMEI
121 LDSLIREMRQ MGQPCDAYQK RLLQLQEQMR ALYKAISVPR VRRASSKGGG GYTCQSGSGW
181 DEFTKHVTSE CLGWMRQQRA EMDMVAWGVD LASVEQHINS HRGIHNSIGD YRWQLDKIKA
241 DLREKSAIYQ LEEEYENLLK ASFERMDHLR QLQNIIQATS REIMWINDCE EEELLYDWSD
301 KNTNIAQKQE AFSIRMSQLE VKEKELNKLK QESDQLVLNQ HPASDKIEAY MDTLQTQWSW
361 ILQITKCIDV HLKENAAYFQ FFEEAQSTEA YLKGLQDSIR KKYPCDKNMP LQHLLEQIKE
421 LEKEREKILE YKRQVQNLVN KSKKIVQLKP RNPDYRSNKP IILRALCDYK QDQKIVHKGD
481 ECILKDNNER SKWYVTGPGG VDMLVPSVGL IIPPPNPLAV DLSCKIEQYY EAILALWNQL
541 YINMKSLVSW HYCMIDIEKI RAMTIAKLKT MRQEDYMKTI ADLELHYQEF IRNSQGSEMF
601 GDDDKRKIQS QFTDAQKHYQ TLVIQLPGYP QHQTVTTTEI THHGTCQDVN HNKVIETNRE
661 NDKQETWMLM ELQKIRRQIE HCEGRMTLKN LPLADQGSSH HITVKINELK SVQNDSQAIA
721 EVLNQLKDML ANFRGSEKYC YLQNEVFGLF QKLENINGVT DGYLNSLCTV RALLQAILQT
781 EDMLKVYEAR LTEEETVCLD LDKVEAYRCG LKKIKNDLNL KKSLLATMKT ELQKAQQIHS
841 QTSQQYPLYD LDLGKFGEKV TQLTDRWQRI DKQIDFRLWD LEKQIKQLRN YRDNYQAFCK
901 WLYDAKRRQD SLESMKFGDS NTVMRFLNEQ KNLHSEISGK RDKSEEVQKI AELCANSIKD
961 YELQLASYTS GLETLLNIPI KRTMIQSPSG VILQEAADVH ARYIELLTRS GDYYRFLSEM
1021 LKSLEDLKLK NTKIEVLEEE LRLARDANSE NCNKNKFLDQ NLQKYQAECS QFKAKLASLE
1081 ELKRQAELDG KSAKQNLDKC YGQIKELNEK ITRLTYEIED EKRRRKSVED RFDQQKNDYD
1141 QLQKARQCEK ENLGWQKLES EKAIKEKEYE IERLRVLLQE EGTRKREYEN ELAKVRNHYN
1201 EEMSNLRNKY ETEINITKTT IKEISMQKED DSKNLRNQLD RLSRENRDLK DEIVRLNDSI
1261 LQATEQRRRA EENALQQKAC GSEIMQKKQH LEIELKQVMQ QRSEDNARHK QSLEEAAKTI
1321 QDKNKEIERL KAEFQEEAKR RWEYENELSK VRNNYDEEII SLKNQFETEI NITKTTIHQL
1381 TMQKEEDTSG YRAQIDNLTR ENRSLSEEIK RLKNTLTQTT ENLRRVEEDI QQQKATGSEV
1441 SQRKQQLEVE LRQVTQMRTE ESVRYKQSLD DAAKTIQDKN KEIERLKQLI DKETNDRKCL
1501 EDENARLQRV QYDLQKANSS ATETINKLKV QEQELTRLRI DYERVSQERT VKDQDITRFQ
1561 NSLKELQLQK QKVEEELNRL KRTASEDSCK RKKLEEELEG MRRSLKEQAI KITNLTQQLE
1621 QASIVKKRSE DDLRQQRDVL DGHLREKQRT QEELRRLSSE VEALRRQLLQ EQESVKQAHL
1681 RNEHFQKAIE DKSRSLNESK IEIERLQSLT ENLTKEHLML EEELRNLRLE YDDLRRGRSE
1741 ADSDKNATIL ELRSQLQISN NRTLELQGLI NDLQRERENL RQEIEKFQKQ ALEASNRIQE
1801 SKNQCTQVVQ ERESLLVKIK VLEQDKARLQ RLEDELNRAK STLEAETRVK QRLECEKQQI
1861 QNDLNQWKTQ YSRKEEAIRK IESEREKSER EKNSLRSEIE RLQAEIKRIE ERCRRKLEDS
1921 TRETQSQLET ERSRYQREID KLRQRPYGSH RETQTECEWT VDTSKLVFDG LRKKVTAMQL
1981 YECQLIDKTT LDKLLKGKKS VEEVASEIQP FLRGAGSIAG ASASPKEKYS LVEAKRKKLI
2041 SPESTVMLLE AQAATGGIID PHRNEKLTVD SAIARDLIDF DDRQQIYAAE KAITGFDDPF
2101 SGKTVSVSEA IKKNLIDRET GMRLLEAQIA SGGVVDPVNS VFLPKDVALA RGLIDRDLYR
2161 SLNDPRDSQK NFVDPVTKKK VSYVQLKERC RIEPHTGLLL LSVQKRSMSF QGIRQPVTVT
2221 ELVDSGILRP STVNELESGQ ISYDEVGERI KDFLQGSSCI AGIYNETTKQ KLGIYEAMKI
2281 GLVRPGTALE LLEAQAATGF IVDPVSNLRL PVEEAYKRGL VGIEFKEKLL SAERAVTGYN
2341 DPETGNIISL FQAMNKELIE KGHGIRLLEA QIATGGIIDP KESHRLPVDI AYKRGYFNEE
2401 LSEILSDPSD DTKGFFDPNT EENLTYLQLK ERCIKDEETG LCLLPLKEKK KQVQTSQKNT
2461 LRKRRVVIVD PETNKEMSVQ EAYKKGLIDY ETFKELCEQE CEWEEITITG SDGSTRVVLV
2521 DRKTGSQYDI QDAIDKGLVD RKFFDQYRSG SLSLTQFADM ISLKNGVGTS SSMGSGVSDD
2581 VFSSSRHESV SKISTISSVR NLTIRSSSFS DTLEESSPIA AIFDTENLEK ISITEGIERG
2641 IVDSITGQRL LEAQACTGGI IHPTTGQKLS LQDAVSQGVI DQDMATRLKP AQKAFIGFEG
2701 VKGKKKMSAA EAVKEKWLPY EAGQRFLEFQ YLTGGLVDPE VHGRISTEEA IRKGFIDGRA
2761 AQRLQDTSSY AKILTCPKTK LKISYKDAIN RSMVEDITGL RLLEAASVSS KGLPSPYNMS
2821 SAPGSRSGSR SGSRSGSRSG SRSGSRRGSF DATGNSSYSY SYSFSSSSIG HLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DSP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 808 nTPM
Expression across tissuesHPA
Tissue
- skin: 808 nTPM
- esophagus: 438 nTPM
- vagina: 275 nTPM
- cervix: 215 nTPM
- salivary gland: 114 nTPM
- pancreas: 105 nTPM
Single-cell type
- suprabasal keratinocytes: 4,672 nCPM
- esophageal suprabasal cells: 3,403 nCPM
- esophageal apical cells: 3,342 nCPM
- ocular epithelial cells: 2,856 nCPM
- basal keratinocytes: 1,933 nCPM
- esophageal basal cells: 1,429 nCPM
Immune cell
- naive B-cell: 2.3 nTPM
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 42 nTPM
- amygdala: 9.5 nTPM
- cerebral cortex: 8 nTPM
- hippocampal formation: 7.9 nTPM
- cerebellum: 5.9 nTPM
- spinal cord: 5.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DSP.
Disease | AllUniProt
Conditions DSP is implicated in, by any mechanism.
- Keratoderma, palmoplantar, striate 2 (SPPK2) MIM:612908
- Cardiomyopathy, dilated, with woolly hair and keratoderma (DCWHK) MIM:605676
- Arrhythmogenic right ventricular dysplasia, familial, 8 (ARVD8) MIM:607450
- Epidermolysis bullosa, lethal acantholytic (EBLA) MIM:609638
- Cardiomyopathy, dilated, with woolly hair, keratoderma, and tooth agenesis (DCWHKTA) MIM:615821
Disease | GeneticClinVar
830 pathogenic / likely-pathogenic of 6,123 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Arrhythmogenic cardiomyopathy with wooly hair and keratoderma
- Arrhythmogenic right ventricular dysplasia 8
- Cardiovascular phenotype
- Cardiomyopathy
- Arrhythmogenic right ventricular cardiomyopathy
Disease | AutoantibodyPubMed
Conditions in which antibodies against DSP are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for DSP from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
28 publications
- Human autoantibodies against desmoplakins in paraneoplastic pemphigus.
1992 · J Clin Invest · RCR 7 · 161 citations - Paraneoplastic pemphigus in children and adolescents.
2002 · Br J Dermatol · RCR 4.4 · 120 citations - Paraneoplastic pemphigus in association with Castleman's disease.
2003 · Br J Dermatol · RCR 3.6 · 106 citations - Is the hemidesmosome a half desmosome? An immunological comparison of mammalian desmosomes and hemidesmosomes.
1986 · Cell Motil Cytoskeleton · RCR 1.9 · 52 citations - Autoantibodies to desmoplakin I and II in patients with erythema multiforme.
1995 · J Exp Med · RCR 1.7 · 55 citations
Show 20 more of 28 total
- Compositionally different desmosomes in the various compartments of the human hair follicle.
1998 · Differentiation · RCR 1.5 · 64 citations - A case of bullous pemphigoid with antidesmoplakin autoantibodies.
1994 · Br J Dermatol · RCR 1.4 · 29 citations - Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major.
1996 · J Invest Dermatol · RCR 1.4 · 38 citations - Erythema multiforme associated human autoantibodies against desmoplakin I and II: biochemical characterization and passive transfer studies into newborn mice.
1998 · J Invest Dermatol · RCR 1.1 · 37 citations - Unique immunobullous disease in a child with a predominantly IgA response to three desmosomal proteins.
1999 · Br J Dermatol · RCR 0.9 · 20 citations - Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies.
2004 · J Am Acad Dermatol · RCR 0.9 · 30 citations - Antidesmoplakin antibodies in pemphigus vulgaris.
2006 · Br J Dermatol · RCR 0.8 · 24 citations - Anti-desmoplakin antibodies in erythema multiforme and Stevens-Johnson syndrome sera: pathogenic or epiphenomenon?
2011 · Eur J Dermatol · RCR 0.7 · 18 citations - Evidence for heterogeneity in the 160/165 x 10(3) Mr glycoprotein components of desmosomes.
1987 · J Cell Sci · RCR 0.6 · 28 citations - Vesicular pemphigoid with antidesmoplakin autoantibodies.
1997 · Br J Dermatol · RCR 0.5 · 10 citations - Detection of autoantibodies to desmoplakin in a patient with oral erythema multiforme.
2007 · Eur J Dermatol · RCR 0.4 · 15 citations - The location of binding sites of pemphigus vulgaris and pemphigus foliaceus autoantibodies: a post-embedding immunoelectron microscopic study.
1997 · Br J Dermatol · RCR 0.4 · 10 citations - Pemphigus vulgaris with autoantibodies to desmoplakin.
2001 · Br J Dermatol · RCR 0.4 · 13 citations - Rituximab, a new treatment for difficult-to-treat chronic erythema multiforme major? Five cases.
2016 · J Eur Acad Dermatol Venereol · RCR 0.4 · 13 citations - Circulating plakin autoantibodies in a patient with erythema multiforme major: are they pathogenic or a manifestation of epitope spreading?
2014 · Australas J Dermatol · RCR 0.3 · 6 citations - Pattern-Specific Loss of Desmoplakin I and II Immunoreactivity in Erythema Multiforme and its Variants: A Possible Aid in Histologic Diagnosis.
2020 · Am J Dermatopathol · RCR 0.2 · 2 citations - Oral and genital lichenoid reactions associated with circulating autoantibodies to desmoplakins I and II: a novel target antigen or example of epitope spreading?
2003 · J Am Acad Dermatol · RCR 0.2 · 7 citations - A case of bullous pemphigoid with antidesmoplakin autoantibodies.
1994 · Dermatology · RCR 0.2 · 3 citations - Enzyme-linked immunosorbent assay for detection of peptide-specific human antidesmoplakin autoantibodies.
2005 · Br J Dermatol · RCR 0.2 · 5 citations - Erythema multiforme associated human autoantibodies against desmoplakin I and II.
1999 · J Invest Dermatol · RCR 0.1 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.6
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction organization
- bundle of His cell-Purkinje myocyte adhesion involved in cell communication
- cell-cell adhesion
- desmosome organization
- epidermis development
- epithelial cell-cell adhesion
- intermediate filament cytoskeleton organization
- intermediate filament organization
- keratinocyte differentiation
- peptide cross-linking
- protein localization to cell-cell junction
- regulation of heart rate by cardiac conduction
- regulation of ventricular cardiac muscle cell action potential
- skin development
- ventricular compact myocardium morphogenesis
- wound healing
Molecular functions
- cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication
- protein kinase C binding
- RNA binding
- scaffold protein binding
- structural constituent of cytoskeleton
- structural molecule activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DSP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DSP as an antibody target. Whether an autoantibody or antibody against DSP could matter depends on whether native DSP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DSP is annotated at the cell surface, where native DSP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label DSP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...